Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Recent publications published by researchers at the MRC WIMM.

Single-cell transcriptomics identifies a WNT7A-FZD5 signaling axis that maintains fallopian tube stem cells in patient-derived organoids

AHMED A., (2023), Cell Reports

The clinicopathological characteristics and survival outcomes of primary expansile vs. infiltrative mucinous ovarian adenocarcinoma: a retrospective study sharing the experience of a tertiary centre.

Nistor S. et al, (2023), Transl Cancer Res, 12, 2682 - 2692

Role of immunotherapy in ovarian cancer: a narrative review

AHMED A. et al, (2022), Gynecology and Pelvic Medicine

Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease.

Serra EG. et al, (2022), Nat Commun, 13

Author Correction: Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation.

Zheng Y. et al, (2022), Nat Commun, 13

Correction to: An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment.

Motohara T. et al, (2022), Oncogene

SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers.

Lu Z. et al, (2022), J Clin Invest, 132

Investigation of the potential mechanisms underlying nuclear F-actin organization in ovarian cancer cells by high-throughput screening in combination with deep learning

AHMED A. et al, (2022), Frontiers in Cell and Developmental Biology

CIDER: an interpretable meta-clustering framework for single-cell RNA-seq data integration and evaluation

Hu Z. et al, (2021), Genome Biology, 22

Neoadjuvant chemotherapy induces genomic and transcriptomic changes in ovarian cancer.

Javellana M. et al, (2021), Cancer Res

Studying Müllerian duct anomalies - from cataloguing phenotypes to discovering causation.

Santana González L. et al, (2021), Dis Model Mech, 14

Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells.

Artibani M. et al, (2021), JCI Insight

General anaesthetic and airway management practice for obstetric surgery in England: a prospective, multicentre observational study.

Odor PM. et al, (2021), Anaesthesia, 76, 460 - 471

Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct

Santana Gonzalez L. et al, (2021), Frontiers in Cell and Developmental Biology

Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct

Santana Gonzalez L. et al, (2021), Frontiers in Cellular and Infection Microbiology

The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers.

Hu Z. et al, (2021), Clin Cancer Res, 27, 1570 - 1579

The Zinc Finger Protein Zbtb18 Represses Expression of Class I Phosphatidylinositol 3-Kinase Subunits and Inhibits Plasma Cell Differentiation.

Xie B. et al, (2021), J Immunol

Subtraction-free and bisulfite-free specific sequencing of 5-methylcytosine and its oxidized derivatives at base resolution.

Liu Y. et al, (2021), Nat Commun, 12

A novel salt inducible kinase 2 inhibitor, ARN-3261, sensitizes ovarian cancer cell lines and xenografts to carboplatin

Fan D. et al, (2021), Cancers

Promises and challenges of adoptive T-cell therapies for solid tumours

AHMED A. et al, (2021), British Journal of Cancer

Load More

1
2
3
4
5

Include forthcoming?